Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

Name: Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Published: 2023
License: Public Domain

Fujian Cancer Hospital · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

malignant melanoma, liver metastases, recombinant human adenovirus type 5, camrelizumab, nab-paclitaxel, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

Related documents